KH

KARIN HOELZER

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
6 agencies contacted
Activity
filings by quarter
Works on

Background

Career

Specific issues

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.
Budget/Appropriations · 2024 Q3
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
Medicare/Medicaid · 2024 Q3
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. H.R.7383/S.1214: RARE Act. Inflation Reduction Act Implementation. PRV Reauthorization. Lab-developed tests.
Pharmacy · 2024 Q3
Rare Disease Initiatives. Newborn Screening. Affordable Care Act (ACA) Issues and Enhancements. Step Therapy. Telehealth. Priority Review Voucher Reauthorization. H.R.6892: Medical Nutrition Equity Act of 2023.
Health Issues · 2024 Q3
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations. Advanced Research Projects Agency - Health (ARPA-H) Appropriations.
Budget/Appropriations · 2024 Q2
Medicare / Medicaid issues impacting patients with rare diseases. H.R.4758/S.2372: Accelerating Kids Access to Care Act. Inflation Reduction Act Implementation.
Medicare/Medicaid · 2024 Q2

Clients

$██,███ / qtrUnlock

Filing history

2024 Q3
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Q3lda.gov →
2024 Q2
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Q2lda.gov →
2024 Q1
NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Q1lda.gov →
Showing recent filings · full history on lda.gov